![]() |
Volumn 44, Issue 3, 2012, Pages 737-739
|
Impact of early ureteric stent removal and cost-benefit analysis in kidney transplant recipients: Results of a randomized controlled study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CEFUROXIME;
COTRIMOXAZOLE;
CYCLOSPORIN;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
ARTICLE;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DEVICE REMOVAL;
DRUG DOSE REDUCTION;
EARLY STENT REMOVAL;
GRAFT RECIPIENT;
GRAFT REJECTION;
HOSPITALIZATION COST;
HUMAN;
INCIDENCE;
INTERMETHOD COMPARISON;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT DURATION;
URETER STENT;
URINARY TRACT DISEASE;
URINARY TRACT INFECTION;
ANTIBIOTIC PROPHYLAXIS;
COST-BENEFIT ANALYSIS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
STENTS;
THAILAND;
TIME AND MOTION STUDIES;
URETER;
|
EID: 84859507118
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2011.11.033 Document Type: Article |
Times cited : (24)
|
References (6)
|